Daphne Pharmaceutical (Group) Co., Ltd. Yunnan
      Daphne, name of goddess of the Moon in Greek mythology, is a symbol of health, purity, beauty and hope. This Group takes her name simply to wish to benefit the public just like the Goddess by safeguarding health for the people. Hopefully all the people are blessed. Daphne's starter and staff feel call of the Goddess and would like to do the best for your health and happiness. 
      Daphne Pharmaceutical Co., Ltd is a private enterprise started in 1994. In 1998, the enterprise was restructured and transformed to a joint stock company mainly dealing with production and processing of Panax notoginseng-based drugs. Presently, the enterprise has 8 subsidiaries, owned or co-owned, with integrated research, manufacturing and trading business covering Panax notoginseng GAP farming, scientific research, production and sales. Additionally, Daphne has sideline business in property development and management, club operation, etc. Since its formation, Daphne sees quality and creditability as its lifeline. With an eye on the global market, we take advantage of the unique Panax notoginseng resource in Wenshan to build a Panax notoginseng industry chain and bring Panax notoginseng-based drugs to the market. Through effort over the past two decades, a Panax notoginseng industry chain has taken shape, consisting of Product R&D Base, Panax notoginseng GAP Farming Bases, TCM Material Processing Base, Production Base, Distribution Base, Int'l Panax Notoginseng Trading Center, Commercial Service Center and Material Service Center. The products have obtained approval documents from state authorities, including 73 for drug products, 2 for functional food supplement products and 1 for foodstuff. The enterprise itself is reputed as one of the first enterprises in Yunnan obtaining GMP and GAP certificates from the State FDA. 
      Since migration into the Panax Notoginseng Drug Park in 2001, Daphne has channeled ¥530m and built China's largest and best equipped international Panax notoginseng trading center and modern production premises, increasing annual production capacity to ¥10b, which marks record highs of Panax notoginseng pharmaceutical business. Daphne's leading products sell well across the country, including Thrombosis Tablets, Qishengli Tablets, Qishengjing Tablets, Panax notoginseng Capsules, Danshen Heart Capsules, Menses Protection Capsules, Panax Notoginseng Trauma Tablets, Qiye Sleep Tablets, Panax Notoginseng Flower & Leaf Granules, Breviscapine, Fibrauretine Tablets, and nationwide well-known food supplement products Panax Notoginseng Likang Tablets and Panax Notoginseng Tangzhikang Capsules. As the enterprise develops, its profitability is increasing. The enterprise has received many titles of honor, including "a national leader in agricultural industrialization", "a national leader in poverty relief", "a national leading rural & town enterprise in branding", "a national model enterprise for produce processing", "a national model organization for national unity and progress", "an innovative non-state-owned enterprise in the Yunnan Province", "a high-tech enterprise in the Yunnan Province ", "a top 100 private enterprise in the Yunnan Province", "a top 10 pharmaceutical enterprise under provincial support program in the Yunnan Province", "a contract-honoring and credible enterprise in the Yunnan Province" and "a top ten enterprise in the Wenshan Prefecture".